Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72(3):558–77.

Article  PubMed  CAS  Google Scholar 

Spadoni I, Zagato E, Bertocchi A, Paolinelli R, Hot E, Di Sabatino A, Caprioli F, Bottiglieri L, Oldani A, Viale G, et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science. 2015;350(6262):830–4.

Article  ADS  PubMed  CAS  Google Scholar 

Albillos A, Lario M, Alvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61(6):1385–96.

Article  PubMed  CAS  Google Scholar 

Tranah TH, Edwards LA, Schnabl B, Shawcross DL. Targeting the gut-liver-immune axis to treat cirrhosis. Gut. 2021;70(5):982–94.

Article  PubMed  CAS  Google Scholar 

Biggins SW, Angeli P, Garcia-Tsao G, Gines P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases. Hepatology. 2021;74(2):1014–48.

Article  PubMed  Google Scholar 

Bajaj JS, O’Leary JG, Wong F, Reddy KR, Kamath PS. Bacterial infections in end-stage liver disease: current challenges and future directions. Gut. 2012;61(8):1219–25.

Article  PubMed  CAS  Google Scholar 

Bajaj JS, Kamath PS, Reddy KR. The evolving challenge of infections in cirrhosis. N Engl J Med. 2021;384(24):2317–30.

Article  PubMed  CAS  Google Scholar 

Kramer B, Nalin AP, Ma F, Eickhoff S, Lutz P, Leonardelli S, Goeser F, Finnemann C, Hack G, Raabe J, et al. Single-cell RNA sequencing identifies a population of human liver-type ILC1s. Cell Rep. 2023;42(1):111937.

Article  PubMed  PubMed Central  Google Scholar 

Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, Portman JR, Matchett KP, Brice M, Marwick JA, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575(7783):512–8.

Article  ADS  PubMed  PubMed Central  CAS  Google Scholar 

Haderer M, Neubert P, Rinner E, Scholtis A, Broncy L, Gschwendtner H, Kandulski A, Pavel V, Mehrl A, Brochhausen C, et al. Novel pathomechanism for spontaneous bacterial peritonitis: disruption of cell junctions by cellular and bacterial proteases. Gut. 2022;71(3):580–92.

Article  PubMed  CAS  Google Scholar 

Moghadamrad S, Hassan M, McCoy KD, Kirundi J, Kellmann P, De Gottardi A. Attenuated fibrosis in specific pathogen-free microbiota in experimental cholestasis- and toxin-induced liver injury. FASEB J. 2019;33(11):12464–76.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut. 2020;69(12):2232–43.

Article  PubMed  CAS  Google Scholar 

Johansson ME, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol. 2013;10(6):352–61.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Grondin JA, Kwon YH, Far PM, Haq S, Khan WI. Mucins in intestinal mucosal defense and inflammation: learning from clinical and experimental studies. Front Immunol. 2020;11:2054.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Patel VC, Lee S, McPhail MJW, Da Silva K, Guilly S, Zamalloa A, Witherden E, Støy S, Manakkat Vijay GK, Pons N, et al. Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial. J Hepatol. 2022;76(2):332–42.

Article  PubMed  CAS  Google Scholar 

Bajaj JS, Kakiyama G, Savidge T, Takei H, Kassam ZA, Fagan A, Gavis EA, Pandak WM, Nittono H, Hylemon PB, et al. Antibiotic-associated disruption of microbiota composition and function in cirrhosis is restored by fecal transplant. Hepatology. 2018;68(4):1549–58.

Article  PubMed  CAS  Google Scholar 

Liu J, Sun J, Wang F, Yu X, Ling Z, Li H, Zhang H, Jin J, Chen W, Pang M, et al. Neuroprotective effects of clostridium butyricum against vascular dementia in mice via metabolic butyrate. Biomed Res Int. 2015;2015:412946.

Article  PubMed  PubMed Central  Google Scholar 

Chopyk DM, Grakoui A. Contribution of the intestinal microbiome and gut barrier to hepatic disorders. Gastroenterology. 2020;159(3):849–63.

Article  PubMed  CAS  Google Scholar 

Bajaj JS, Betrapally NS, Hylemon PB, Thacker LR, Daita K, Kang DJ, White MB, Unser AB, Fagan A, Gavis EA, et al. Gut microbiota alterations can predict hospitalizations in cirrhosis independent of diabetes mellitus. Sci Rep. 2015;5:18559.

Article  ADS  PubMed  PubMed Central  CAS  Google Scholar 

Bloom PP, Rao K, Bassis CM, Zhou SY, Nojkov B, Owyang C, Young VB, Lok AS. Duodenal permeability is associated with mucosal microbiota in compensated cirrhosis. Clin Transl Gastroenterol. 2022;13(10):e00522.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Ji F, Guo J, Shi D, Fang D, Li L. Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology. Sci Rep. 2016;6:34055.

Article  ADS  PubMed  PubMed Central  CAS  Google Scholar 

Bajaj JS, Kakiyama G, Zhao D, Takei H, Fagan A, Hylemon P, Zhou H, Pandak WM, Nittono H, Fiehn O, et al. Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis. Alcohol Clin Exp Res. 2017;41(11):1857–65.

Article  PubMed  CAS  Google Scholar 

Zou J, Liu C, Jiang S, Qian D, Duan J. Cross talk between gut microbiota and intestinal mucosal immunity in the development of ulcerative colitis. Infect Immun. 2021;89(9):e0001421.

Article  PubMed  Google Scholar 

Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011;12(5):383–90.

Article  PubMed  CAS  Google Scholar 

Lv J, Meng S, Gu Q, Zheng R, Gao X, Kim JD, Chen M, Xia B, Zuo Y, Zhu S, et al. Epigenetic landscape reveals MECOM as an endothelial lineage regulator. Nat Commun. 2023;14(1):2390.

Article  ADS  PubMed  PubMed Central  CAS  Google Scholar 

Zuluaga P, Sanvisens A, Teniente-Serra A, El Ars O, Fuster D, Quirant-Sánchez B, Martínez-Cáceres E, Muga R. Loss of naive T lymphocytes is associated with advanced liver fibrosis in alcohol use disorder. Drug Alcohol Depend. 2020;213:108046.

Article  PubMed  CAS  Google Scholar 

Bottois H, Ngollo M, Hammoudi N, Courau T, Bonnereau J, Chardiny V, Grand C, Gergaud B, Allez M, Le Bourhis L. KLRG1 and CD103 expressions define distinct intestinal tissue-resident memory CD8 T cell subsets modulated in crohn’s disease. Front Immunol. 2020;11:896.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Topham DJ, Reilly EC. Tissue-resident memory CD8(+) T cells: from phenotype to function. Front Immunol. 2018;9:515.

Article  PubMed  PubMed Central  Google Scholar 

You Z, Li Y, Wang Q, Zhao Z, Li Y, Qian Q, Li B, Zhang J, Huang B, Liang J, et al. The clinical significance of hepatic CD69(+) CD103(+) CD8(+) resident-memory T cells in autoimmune hepatitis. Hepatology. 2021;74(2):847–63.

Article  PubMed  CAS  Google Scholar 

Munoz L, Caparros E, Albillos A, Frances R. The shaping of gut immunity in cirrhosis. Front Immunol. 2023;14:1139554.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kronsten VT, Woodhouse CA, Zamalloa A, Lim TY, Edwards LA, Martinez-Llordella M, Sanchez-Fueyo A, Shawcross DL. Exaggerated inflammatory response to bacterial products in decompensated cirrhotic patients is orchestrated by interferons IL-6 and IL-8. Am J Physiol Gastrointest Liver Physiol. 2022;322(5):G489–99.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hartmann P, Chen P, Wang HJ, Wang L, McCole DF, Brandl K, Starkel P, Belzer C, Hellerbrand C, Tsukamoto H, et al. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology. 2013;58(1):108–19.

Article  PubMed  CAS  Google Scholar 

Noah TK, Lo YH, Price A, Chen G, King E, Washington MK, Aronow BJ, Shroyer NF. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity. Gastroenterology. 2013;144(5):1012-1023.e1016.

Article  PubMed  CAS